Charles Schwab Investment Management Inc. Buys 342,253 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Charles Schwab Investment Management Inc. boosted its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 204.7% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 509,430 shares of the construction company's stock after buying an additional 342,253 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.66% of Aspen Aerogels worth $14,106,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the business. Intech Investment Management LLC purchased a new position in Aspen Aerogels during the third quarter worth about $497,000. Quest Partners LLC lifted its position in Aspen Aerogels by 263.3% during the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock valued at $205,000 after buying an additional 5,361 shares in the last quarter. Sargent Investment Group LLC grew its stake in Aspen Aerogels by 1.8% during the third quarter. Sargent Investment Group LLC now owns 323,369 shares of the construction company's stock worth $8,954,000 after buying an additional 5,830 shares during the period. Black Swift Group LLC raised its stake in shares of Aspen Aerogels by 34.1% in the 3rd quarter. Black Swift Group LLC now owns 106,500 shares of the construction company's stock valued at $2,949,000 after acquiring an additional 27,100 shares during the period. Finally, Oppenheimer & Co. Inc. lifted its stake in shares of Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock worth $2,839,000 after purchasing an additional 64,154 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Price Performance

NYSE:ASPN traded up $1.08 during mid-day trading on Monday, reaching $14.44. 1,156,409 shares of the stock were exchanged, compared to its average volume of 1,631,341. The business has a fifty day moving average price of $18.60 and a 200 day moving average price of $23.45. The firm has a market capitalization of $1.18 billion, a PE ratio of 1,428.43 and a beta of 2.12. Aspen Aerogels, Inc. has a 1-year low of $10.75 and a 1-year high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Analyst Upgrades and Downgrades

Several research firms recently commented on ASPN. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, November 13th. TD Cowen raised their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a "buy" rating in a research note on Tuesday, August 20th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. Finally, HC Wainwright restated a "buy" rating and set a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus target price of $28.70.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.